Ottavio de Cobelli
Overview
Explore the profile of Ottavio de Cobelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
404
Citations
3556
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Longoni M, Penaranda N, Marmiroli A, Falkenbach F, Le Q, Nicolazzini M, et al.
Urology
. 2025 Mar;
PMID: 40057122
Objective: To investigate whether bimodal therapy (BMT) or trimodal therapy (TMT) differ from radical cystectomy (RC) + perioperative chemotherapy (CT) in cancer control outcomes among patients with non-organ-confined (NOC; T3-4...
2.
Marvaso G, Corrao G, Zaffaroni M, Vincini M, Lorubbio C, Gandini S, et al.
Lancet Oncol
. 2025 Mar;
26(3):300-311.
PMID: 40049196
Background: Metastasis-directed therapy by stereotactic body radiotherapy (SBRT) has been shown to improve clinical outcomes in the oligometastatic prostate cancer setting. We aimed to investigate whether short-course androgen deprivation therapy...
3.
Penaranda N, Di Bello F, Falkenbach F, Marmiroli A, Longoni M, Le Q, et al.
J Racial Ethn Health Disparities
. 2025 Mar;
PMID: 40035954
Objective: Previously, African American race/ethnicity predisposed to higher rate of adverse in-hospital outcomes after radical cystectomy (RC). We tested whether this association applies to contemporary RC patients. Methods: Patients were...
4.
de Angelis M, Siech C, Jannello L, Di Bello F, Penaranda N, Scilipoti P, et al.
Urol Oncol
. 2025 Feb;
PMID: 39986912
Introduction: It is unknown whether sex-related differences in response to neoadjuvant (NAC) or adjuvant chemotherapy (ADJ) exist in urothelial carcinoma patients treated with radical cystectomy (RC). We addressed these knowledge...
5.
Longoni M, Di Bello F, Penaranda N, Falkenbach F, Marmiroli A, Le Q, et al.
Clin Genitourin Cancer
. 2025 Jan;
23(2):102300.
PMID: 39863496
Introduction: In NCCN favorable intermediate-risk (FIR) prostate cancer (PCa) patients treated with radical prostatectomy (RP), we tested the effect of upstaging and upgrading on cancer-specific mortality (CSM). Methods: Within the...
6.
Di Bello F, Penaranda N, Marmiroli A, Longoni M, Falkenbach F, Le Q, et al.
J Endourol
. 2025 Jan;
39(2):127-134.
PMID: 39829349
To test whether the contemporary robot-assisted nephroureterectomy (RNU) is associated with more favorable in-hospital outcomes than historical RNU, relative to the same endpoints in open NU (ONU). Within the National...
7.
Di Bello F, Scheipner L, Baudo A, de Angelis M, Jannello L, Siech C, et al.
Urol Oncol
. 2025 Jan;
PMID: 39827002
Introduction: To test for cancer specific mortality (CSM) differences after either radical prostatectomy (RP) or radiotherapy (RT) in incidental prostate cancer (IPCa) patients. Patients And Methods: Within the Surveillance, Epidemiology,...
8.
Siech C, de Angelis M, Jannello L, Di Bello F, Penaranda N, Goyal J, et al.
Crit Care Med
. 2025 Jan;
53(1):e132-e139.
PMID: 39774205
Objectives: To examine critical care therapy rates after cytoreductive nephrectomy in metastatic kidney cancer patients. Design, Setting, And Patients: Relying on the National Inpatient Sample (2000-2019), we addressed critical care...
9.
Garcia C, Incesu R, Barletta F, Morra S, Scheipner L, Baudo A, et al.
Sci Rep
. 2025 Jan;
15(1):967.
PMID: 39762392
To test for rates of inpatient palliative care (IPC) in metastatic testicular cancer patients receiving critical care therapy (CCT). Within the Nationwide Inpatient Sample (NIS) database (2008-2019), we tabulated IPC...
10.
Siech C, de Angelis M, Jannello L, Di Bello F, Penaranda N, Goyal J, et al.
Int J Cancer
. 2024 Dec;
PMID: 39740082
Survival differences in rare histological prostate cancer (PCa) subtypes relative to age-matched population-based controls are unknown. Within Surveillance, Epidemiology, and End Results database (2004-2020), newly diagnosed (2004-2015) PCa patients were...